Ahmedabad (Gujarat) [India], February 2 (ANI): Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.

The company is also planning to make the vaccine available in the private market.

Also Read | Jailed Gangster Mukhtar Ansari Gets Bail from Ghazipur Session Court.

ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet® needle-free system, Tropis®, on day 0, day 28 and day 56.

The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs 93 per dose excluding GST

Also Read | India Reports 1,61,386 New COVID-19 Cases, 1,733 Deaths in Past 24 Hours; Positivity Rate Drops to 9.26%.

Zydus VTEC manufactures the drug substance for the needle-free DNA Plasmid vaccine, ZyCoV-D. The manufacturing process and in-process material transfers within the plant are automated.

Zydus has also entered into a definitive agreement with Shilpa Medicare Limited, a contract manufacturing organization to produce mutually agreeable doses of ZyCoV-D.

The company also entered into an agreement with Enzychem Lifesciences of the Republic of Korea for the manufacturing license and technology transfer for the Plasmid DNA Vaccine. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)